– BT-11 was safe and well-tolerated at all doses evaluated and supports initiation of Phase 2 program in IBD patients in 1 st half of 2019 – BLACKSBURG, Va.–(BUSINESS WIRE)–January 7, 2019– Landos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results